Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)
Clinical trial NCT01971554 · COMPLETED
Trial details
- NCT number
- NCT01971554
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-14
- Primary completion
- 2014-04-26
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.